LBCI Lebanon
LBCI Lebanon
Ready to play
Ready to play
Researchers at the University of Cambridge in the UK announced the development of a new vaccine designed using artificial intelligence techniques. It is the first of its kind in the world, aimed at providing broad protection against the coronavirus family, current variants, and animal viruses that may cause future pandemics. The vaccine relies on analyzing the genetic codes of viruses to design a super antigen that enhances the immune response against a wide range of viruses. Initial experiments on 39 volunteers have shown it to be safe, while studies are currently underway to evaluate its efficacy. The team aims to use this technique to develop universal vaccines for influenza and Ebola. Experts believe that artificial intelligence could help accelerate and improve the development of vaccines to combat global health threats.
Notice: This Is an AI-Generated Summary
Comments (0)